Navigation Links
The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
Date:3/18/2009

AURORA, Colo., March 18 /PRNewswire/ -- Pharmatech Oncology has been selected by the Fitzsimons Redevelopment Authority to be a preferred vendor to the Colorado Science + Technology Park at Fitzsimons. The Technology Park is home to 25 pharmaceutical and biotechnology companies. The majority of the companies are in the research stage with a select number of companies expanding their research on commercial products. Pharmatech Oncology was chosen as a preferred vendor for its Contract Research, Site Management, and Data Management services within the realm of managing clinical research trials.

Forest City Science + Technology Group, in partnership with the Fitzsimons Redevelopment Authority, is developing the 184-acre Colorado Science + Technology Park at Fitzsimons. The synergy created by the research and development from the private bioscience companies, along with the clinical research endeavors of the University of Colorado Hospital and The Children's Hospital, allows for collaboration, cooperation and scientific advancement. "Colorado has experienced a considerable amount of growth in this industry and we are very fortunate to have Pharmatech Oncology helping contribute to the Fitzsimons campus becoming a world-class research campus," affirms Vicki Jenings, Director of Business Relations for the Fitzsimons Redevelopment Authority.

Rob Bohacs, Director of Business Development, Pharmatech Oncology, states that "Pharmatech Oncology is privileged to be a preferred vendor to the Colorado Science + Technology Park and to serve the companies within the life sciences cluster. It's exciting to witness the expansion of the Technology Park, as well as the significant medical research that is being conducted by its affiliated companies."

About Pharmatech Oncology:

Pharmatech Oncology, headquartered in Denver, Colorado, is a Research Management Organization (RMO) dedicated to the highest quality of clinical research. Pharmatech Oncology provides services of a Site Management Organization (SMO) and a Contract Research Organization (CRO) with a focus in oncology clinical trials. With Data Management as a separate business entity, it allows for management of data for other types of research aside from strictly oncology. Through an organized research network, the Company focuses on the development and utilization of therapeutic products among sponsors, investigators, and patients. For more information about Pharmatech Oncology, please visit www.pharmatechoncology.com.

About The Fitzsimons Redevelopment Authority/Colorado Science + Technology Park at Fitzsimons:

The Fitzsimons Redevelopment Authority oversees the commercial development of the Fitzsimons Life Science District, ensuring its legacy as the center of life science pursuits in the Rocky Mountain Region. The Colorado Science + Technology Park at Fitzsimons is a 184-acre medical and research park located in the Life Science District, which is being developed by Forest City Science + Technology Group, a leading developer of life science campuses across the country. Companies that locate in the park will benefit from close proximity to the talent and core laboratory facilities of the University of Colorado Hospital, University of Colorado Denver research and education facilities at the Anschutz Medical Campus, The Children's Hospital and future Veterans Affairs Hospital.

Key Words: Oncology, Clinical Trials, Cancer, Patients, Contract Research, Site Management, Data Management, Research, Network, Fitzsimons


'/>"/>
SOURCE Pharmatech Oncology
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
2. VeraSun Energy Selects Valero as Successful Bidder for Seven Facilities
3. USAID Selects Abt Associates to Lead Team in Strengthening Mexico Private Sector Competitiveness
4. The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape
5. Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009
6. The IN VIVO Blog Selects First Annual Deal of the Year
7. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
8. WuXi AppTec Selects H-Cube from ThalesNano for Laboratory-based Hydrogenation
9. Community Care Physicians Selects Allscripts Practice Management System for 190 Physicians in New York Capitol Region
10. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
11. Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... of 13 prestigious awards honoring scientists who have made outstanding ... a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
Breaking Biology News(10 mins):